Ionis Pharmaceuticals, Inc.
Modulation of Huntington expression
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of huntingtin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate Huntington's disease, or a symptom thereof.
Status:
Grant
Type:
Utility
Filling date:
12 Oct 2020
Issue date:
23 Aug 2022